STVN.US Stevanato Group SpA

Healthcare Health Care Equipment & Supplies USA Stocks
83.58 USD
Close of Nov 18, 2026
12.05 23.92
Market cap
USD 4.17B
P/E
25.8x
P/B
2.41x
ROE
7.7%
Dividend yield
0.40%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is STVN.US undervalued?

Graham number
Price83.58
Graham value50.18
Premium66.5%

STVN.US trades 66.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Stevanato Group SpA fundamental analysis

No fundamental analysis for Stevanato Group SpA yet.

Stevanato Group SpA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic s…

Full company profile